Interleukin Genetics Inc. Reports First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Interleukin Genetics, Inc. (OTCQB: ILIU) today issued financial and operational results for the first quarter ended March 31, 2013.
Revenue for the quarter ended March 31, 2013 was $487,000, compared to $678,000 for the same period in 2012. The decrease is primarily attributable to decreased genetic testing revenue recognized from genetic tests processed as a result of sales through the Amway Global sales channel.
Help employers find you! Check out all the jobs and post your resume.
Interleukin Genetics, Inc. (OTCQB: ILIU) today issued financial and operational results for the first quarter ended March 31, 2013.
Revenue for the quarter ended March 31, 2013 was $487,000, compared to $678,000 for the same period in 2012. The decrease is primarily attributable to decreased genetic testing revenue recognized from genetic tests processed as a result of sales through the Amway Global sales channel.
Help employers find you! Check out all the jobs and post your resume.